← Back to Search

PCIP for Post-Traumatic Stress Disorder (APCIP Trial)

N/A
Recruiting
Led By Lauren C Ng, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient is able to complete study activities in English
Patients must be at least 12 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 0 baseline, 10 months
Awards & highlights

APCIP Trial Summary

This trial will help assess whether the Primary Care Intervention for PTSD is an effective and sustainable treatment option for PTSD patients.

Who is the study for?
This trial is for adolescents at least 12 years old with probable PTSD, who can participate in English. A legal guardian must consent if under 18. Excluded are those with recent suicidal plans or attempts, or inability to consent or complete procedures in English.Check my eligibility
What is being tested?
The study tests the Primary Care Intervention for PTSD (PCIP) against usual treatment, assessing health outcomes and telehealth delivery. It involves patient and caregiver participation, symptom tracking, interviews, and fidelity checks of the intervention process.See study design
What are the potential side effects?
Since this trial focuses on a non-medical intervention (PCIP), traditional medication side effects aren't applicable. However, participants may experience discomfort discussing traumatic events during therapy sessions.

APCIP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can complete study activities in English.
Select...
I am at least 12 years old.

APCIP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 0 baseline, 10 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 0 baseline, 10 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in PTSD Knowledge
Change in Self-Reported Arousal
Change in Stress Management Skill Use
+2 more
Secondary outcome measures
Change in Adverse Childhood Experiences
Change in Anxiety Symptoms
Change in Depression Symptoms
+6 more

APCIP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BREATHE Primary Care Intervention for PTSD (PCIP)Experimental Treatment1 Intervention
BREATHE PCIP is a treatment for Post-Traumatic Stress Disorder (PTSD) symptoms for use with individuals who have a diagnosis of PTSD or "probable PTSD." The treatment will be considered delivered when patients have learned and practiced breathing retraining and have discussed the symptoms of PTSD (Sessions 1 through 3).
Group II: Treatment As UsualActive Control1 Intervention
Receive standard care treatment and provided information on free or low cost mental health care referrals in the Los Angeles Area.

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,532 Previous Clinical Trials
10,265,224 Total Patients Enrolled
Lauren C Ng, PhDPrincipal InvestigatorUniversity of California, Los Angeles
2 Previous Clinical Trials
40 Total Patients Enrolled

Media Library

BREATHE Primary Care Intervention for PTSD (PCIP) Clinical Trial Eligibility Overview. Trial Name: NCT05088915 — N/A
Post-Traumatic Stress Disorder Research Study Groups: Treatment As Usual, BREATHE Primary Care Intervention for PTSD (PCIP)
Post-Traumatic Stress Disorder Clinical Trial 2023: BREATHE Primary Care Intervention for PTSD (PCIP) Highlights & Side Effects. Trial Name: NCT05088915 — N/A
BREATHE Primary Care Intervention for PTSD (PCIP) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05088915 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the aggregate amount of participants in this experiment?

"Affirmative. The information provided on clinicaltrials.gov demonstrates that this experiment, which was initially published on 3rd January 2022, is still recruiting participants. 45 volunteers are required from a single medical facility to participate in the trial."

Answered by AI

What are the key objectives of this clinical trial?

"The primary aim of this trial is to measure the transformation in trauma-associated cognitions over a 10 month period from baseline. Secondary objectives are focused on alterations in adverse childhood experiences using PEARLS, shifts in trauma symptoms via the CPSS-5-SR Self Report, and transformations in PTSD related signs with UCLA Child/Adolescent PTSD Reaction Index for DSM-5 Brief Screen."

Answered by AI

Who is validated to participate in this clinical experiment?

"To qualify for the trial, individuals should have a diagnosis of PTSD and be between 12 and 22 years old. Currently, 45 participants are needed to complete the study."

Answered by AI

Are participants being accepted for this research project presently?

"Affirmative. Clinicaltrials.gov demonstrates that, as of February 25th 2022, this clinical trial is currently searching for 45 participants from a single location. This study was initially listed on March 1st 2022."

Answered by AI

Are individuals aged 35 and older eligible to participate in this clinical experiment?

"The study requires that applicants be younger than 23 and older than 11. Per the clinical trial registry, there are 288 trials for patients under 18 years of age and 865 for those above 65."

Answered by AI

Who else is applying?

What state do they live in?
California
How old are they?
65+
18 - 65
What site did they apply to?
University of California Los Angeles
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
~14 spots leftby Apr 2025